542 results on '"Whalen, Jeanne"'
Search Results
2. FDA seizes two Glaxo drugs on production-quality concerns
3. Novartis expands generics range for $8.4 billion; acquisition of two firms aims at growing demand for broader drug portfolio
4. Big Pharma, flush with cash, is looking acquisitive
5. Demand lags for Viagra and its rivals
6. WHO crisis team scrambles to fight disease outbreaks
7. Competing with big pharma; three midsize drug makers are faring better than larger rivals
8. AstraZeneca plans an overhaul after latest product setback
9. New leukemia drugs may prove more potent than Gleevec
10. Generic maker pulls HIV drugs from WHO use
11. Merck's earnings are hurt by Vioxx, Lilly reports higher profit but sales of Zyprexa sink; Novartis, others post gains
12. New flu worry: antiviral drugs also may be in short supply
13. Contagious turmoil; closing of flu-vaccine plant by British regulators took Chiron, U.S. by surprise
14. U.S. flu vaccines face rationing as plant is shut; British regulators suspend production at Chiron unit; Europe, Asia to feel effects
15. AstraZeneca needs R&D magic; Exanta and Crestor setbacks put pressure on product pipeline
16. Alternative medicine: a big drug maker moves to play down mass-market pills; Roche seeks pricey products in specialties like cancer and rejects megamergers; Pfizer's edge in sales muscle
17. Clinical trials get tighter security; medical journals decide against publishing results unless study has registered
18. Sanofi-Synthelabo's net rises; Bayer profit is flat due to write-off of firm's stake in venture
19. Eli Lilly profit falls on charges; AstraZeneca net climbs 25%
20. Drug firms post mixed results; Pfizer records strong earnings; Merck, Wyeth slip
21. Doctor defends linking suicide, antidepressants
22. Novartis shares belie growth; bulls shrug off merger uncertainty, citing smart moves in past
23. Glaxo CEO: litigation is 'getting out of control'
24. AstraZeneca looks within; drug maker won't rely on mergers or acquisitions to grow
25. Belgian drug company beefs up to take on U.S. biotech rivals
26. Profit falls for Glaxo, AstraZeneca; costs, dollar, competition hurt U.K. drug producers, but Aventis net rises 15%
27. European patients lobby EC to ease its ban on drug ads
28. Sanofi-Aventis deal could spur other mergers; drug makers are facing patent-expiration pressure as lab productivity falls
29. Tough drill: for West's oil giants, vast fields in Russia prove hard to tap; Exxon Mobil's awkward dance with Moscow show perils; Putin's veiled warnings; a tycoon remains in jail
30. In Siberia, a race to write a dictionary before the subject dies; as Khanty dialects fade, Ms. Parnyuk scribbles; Qaqi and the Three Bears
31. Third party may enter Yukos talks; participants in deal weigh pulling in Western oil firm to purchase Sibneft stake
32. Yukos and Sibneft to unwind plans for oil merger
33. Russian oil-output growth slows
34. Duma election deposits Putin in driver's seat; after ouster of liberals, president is change agent amid new national mood
35. Kremlin backers show strength in Russia vote; parliamentary results would likely help Putin in his expected 2nd term
36. Balance of power: China's growing thirst for oil remakes the global market; Beijing's buying keeps prices high - and could reshape politics of Middle East; growing closer to the Saudis
37. New pressures on Yukos deal seen from Kremlin
38. Russia may reject Kyoto Protocol in 'current form.'
39. Yukos would cede management jobs to rescue merger
40. Sibneft calls halt to Yukos merger as feud intensifies
41. Russia to shutter tax havens in bid for oil revenue
42. BP moves forward on Siberian gas venture
43. Yukos executives seek to allay investor concern; amid their assurances, the departed CEO is said to mull political campaign
44. Kremlin official questions freeze of Yukos shares; Putin chief of staff warns prosecutors to consider economic fallout of moves
45. Power struggle; Kremlin battle with oil giant shakes up Russia; freezing shares of Yukos points to political motives, signs of authoritarianism
46. American finds himself atop Russian oil giant in turmoil
47. For Russia's oil tycoons, it's like old times; critics of president Putin say he is tackling barons using Soviet-style tactics
48. Yukos arrest resonates for big oil; chairman's detention imperils Russian rebound and foreign confidence
49. From red to noir: Russian film stages a gritty comeback; tales of turmoil revive a legendary industry; 'Potemkin,' meet 'Boomer.'
50. Russia seeks economic guarantee in Kyoto Pact
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.